References [1] R. A. Adams, A. M. Meade, A. Madi, D. Fisher, E. Kay, S. Kenny, R. S. Kaplan, and T. S. Maughan. Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC

Source URL: www.toumiak.com

• Clinical medicine
• Cancer
• Medicine
• Cancer treatments
• Organofluorides
• Angiogenesis inhibitors
• Eli Lilly and Company
• Bevacizumab
• FOLFIRI
• FOLFOXIRI
• Chemotherapy regimen
• Cetuximab

FOLFOXIRI Irinotekan Oxaliplatin Calciumfolinat 5-Fluorouracil

Source URL: www.cancercentrum.se